Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Porphyria, Erythropoietic”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Early research (Phase 1)Study completedNCT02452372
What this trial is testing

Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria
Alnylam Pharmaceuticals 40
Not applicableStudy completedNCT01880983
What this trial is testing

Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))

Who this might be right for
Erythropoietic Protoporphyria (EPP)
University of Alabama at Birmingham 150
Not applicableStudy completedNCT00005103
What this trial is testing

Study of the Pathogenesis of Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
National Center for Research Resources (NCRR) 120
Large-scale testing (Phase 3)Study completedNCT01605136
What this trial is testing

Phase III Confirmatory Study in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 93
Early research (Phase 1)Study completedNCT00004398
What this trial is testing

Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria

Who this might be right for
Porphyria
National Center for Research Resources (NCRR) 24
Not applicableStudy completedNCT05882136
What this trial is testing

Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System

Who this might be right for
Porphyrias, Hepatic
National Institute of Cardiology, Warsaw, Poland 180
Not applicableEnded earlyNCT01550705
What this trial is testing

Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria (EPP)X Linked Erythropoietic Protoporphyria
University of Utah 11
Testing effectiveness (Phase 2)Study completedNCT02180412
What this trial is testing

Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria

Who this might be right for
Acute Porphyrias
The University of Texas Medical Branch, Galveston 20
Testing effectiveness (Phase 2)Study completedNCT02949830
What this trial is testing

Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria
Alnylam Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT06971900
What this trial is testing

GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria (EPP)
Portal Therapeutics, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT05854784
What this trial is testing

Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)

Who this might be right for
Variegate Porphyria
Clinuvel Pharmaceuticals Limited 6
Not applicableApproved For MarketingNCT04056481
What this trial is testing

Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria

Who this might be right for
Acute Hepatic Porphyria
Alnylam Pharmaceuticals
Not applicableActive Not RecruitingNCT02935400
What this trial is testing

Acute Porphyria Biomarkers for Disease Activity

Who this might be right for
Acute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria
The University of Texas Medical Branch, Galveston 50
Early research (Phase 1)Study completedNCT02082860
What this trial is testing

Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria

Who this might be right for
Acute Intermittent Porphyria
Digna Biotech S.L. 8
Not applicableStudy completedNCT00006057
What this trial is testing

Diagnostic and Screening Study of Genetic Disorders

Who this might be right for
Tay-Sachs DiseasePorphyria, ErythropoieticLeukodystrophy, Globoid Cell+1 more
National Center for Research Resources (NCRR) 50
Not applicableUnknownNCT00206869
What this trial is testing

Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Bispebjerg Hospital
Large-scale testing (Phase 3)Study completedNCT00418795
What this trial is testing

Porphozym in the Treatment of Acute Attacks in AIP

Who this might be right for
Acute Intermittent Porphyria
Zymenex A/S 36
Testing effectiveness (Phase 2)Ended earlyNCT02922413
What this trial is testing

Panhematin for Prevention of Acute Attacks of Porphyria

Who this might be right for
Acute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria
The University of Texas Medical Branch, Galveston 13
Not applicableStudy completedNCT02979249
What this trial is testing

Oral Iron for Erythropoietic Protoporphyrias

Who this might be right for
Erythropoietic ProtoporphyriaEPPX-linked Protoporphyria+1 more
Icahn School of Medicine at Mount Sinai 16
Not applicableStudy completedNCT00213772
What this trial is testing

Risk Factors of Porphyria Cutanea Tarda (PCT)

Who this might be right for
Porphyria Cutanea Tarda
University Hospital, Strasbourg, France 280
Next Page